Identification of Hepatitis C Virus (HCV) Subtype 1b Strains That Are Highly, or Only Weakly, Associated with Hepatocellular Carcinoma on the Basis of the Secondary Structure of an Amino-Terminal Portion of the HCV NS3 Protein
about
Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathwayDecreased apoptosis in advanced-stage/high-grade hepatocellular carcinoma complicating chronic hepatitis C is mediated through the downregulation of p21 rasOccurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy.Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma.Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy.Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.Genetic similarity of hepatitis C virus and fibrosis progression in chronic and recurrent infection after liver transplantation.Secondary structure of the amino-terminal region of HCV NS3 and virological response to pegylated interferon plus ribavirin therapy for chronic hepatitis C.Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis.
P2860
Q24307549-8DCA0833-2AD0-4155-ADF1-E4B6E2569772Q36967501-0D9ED7A4-05D1-4E85-A314-4C3BE8ACFFBEQ40148468-5C6C3042-9060-48E3-9471-1F96AB67D382Q40523505-180E2B80-877B-4B82-80AD-6BD71C3E48D4Q42981430-859CBC88-C0A9-458E-953F-42DBC4CF41BFQ42983421-B3D5F36B-EFEC-44D7-A7CF-2BF8E024F3A3Q42987712-EB19E745-8748-40BA-BD3E-5EE9E13E32ACQ42997812-3688EC7F-C89A-4F39-A7AD-93BBD5343513Q42997927-6D5EDB62-6844-49E6-9830-51A6974D6250Q43035316-1FB14B24-D8CA-4799-B12F-755BAA0C8993Q43036185-8869BFCF-B782-4798-95BE-C7FAD6498A71Q43039569-E2E7A43A-C63E-4C63-BA1B-4B39A8414393Q45399951-ED4EEAA5-6ABE-4ECA-B9A1-50C9A64CBA3B
P2860
Identification of Hepatitis C Virus (HCV) Subtype 1b Strains That Are Highly, or Only Weakly, Associated with Hepatocellular Carcinoma on the Basis of the Secondary Structure of an Amino-Terminal Portion of the HCV NS3 Protein
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@ast
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@en
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@nl
type
label
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@ast
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@en
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@nl
prefLabel
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@ast
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@en
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@nl
P2093
P2860
P1476
Identification of Hepatitis C ...... Portion of the HCV NS3 Protein
@en
P2093
Motoko Nagano-Fujii
Rachmat Hidajat
Ruth Huab Florese
Satoshi Ogata
Seitetsu Yoon
Sumio Kawata
Takafumi Saito
P2860
P304
P356
10.1128/JCM.41.7.2835-2841.2003
P407
P577
2003-07-01T00:00:00Z